STONY BROOK, NY--(Marketwired - January 29, 2016) - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, announced that Dr. James Hayward, President & CEO, will participate at the Source Capital Group 2016 Disruptive Growth and Healthcare Conference in New York City on February 11 at 12:30 p.m. Eastern time and host one-on-one meetings with investors throughout the day. Dr. Hayward's presentation will be webcast and available at or through the Investor Relations section of the company's website at

Dr. Hayward will also participate in a panel discussion at the conference at 1:30 p.m. Eastern time. The panel, "Disruptive Innovation," will cover disruptive innovations, technologies and business models.

About Applied DNA Sciences

Applied DNA Sciences makes life real and safe by providing biotechnology-driven solutions to help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Patented botanical DNA solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature DNA is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, for textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators.

Go to for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, which is available at APDN undertakes no obligation to update publicly any forward looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contact Information:

Investor contact:
Debbie Bailey

Sanjay M. Hurry

Media contact:
Susan Forman
Dian Griesel Int'l.